Skip to content

A CLINICAL TRAIL TO STUDY COMPARISON BETWEEN ROPIVACAINE WITH OR WITHOUT MAGNESIUM SULPHATE FOR POST OPERATIVE PAIN RELIEF IN LOWER ABDOMINAL SURGERY BY USING TRANSVERSUS ABDOMINIS PLANE BLOCK

A COMPARATIVE STUDY BETWEEN ROPIVACAINE WITH OR WITHOUT MAGNESIUM SULPHATE FOR POST OPERATIVE ANALGESIA IN LOWER ABDOMINAL SURGERY BY USING TRANSVERSUS ABDOMINIS PLANE BLOCK

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040012
Enrollment
60
Registered
2022-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Control Intervention1: Ropivacaine: Dose-Inj. Ropivacaine 0.25% Of 20ml With 2.5ml Of Normal Saline for 6-8hours Control Intervention2: Magnesium Sulphate: Ropivacaine + Mag

Sponsors

Dr Abhinetri Danashetti
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients posted for lower abdominal surgery. 2.Age group 18-60 years. 3.Patients of American Society of Anaesthesiology grade 1 and II.

Exclusion criteria

Exclusion criteria: 1. Patients on any opioid or any sedative medication in the week prior to the surgery. 2. Patients with history of alcohol or drug abuse. 3. Patients who have known allergies to any of test drugs. 4. Patients with coagulation disorders or on anti coagulant drugs. 5. Patients with cardiac disease (heart block, premature ventricular contractions, significant bradyarrhythmias, left ventricular failure.) 6. Patients with respiratory diseases.

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Ropivacaine with or without Magnesium sulphate for postoperative analgesia.Timepoint: From Time of Injection to First 6-8 Hours After The Surgery

Secondary

MeasureTime frame
To Study Systemic Side Effects.Timepoint: From Time Of Injection To 6hr, 12hr, 24hr After The Surgery

Countries

India

Contacts

Public ContactDr Abhinetri Danashetti

HKE Societys M R Medical College

nandyalnanda@gmail.com9663420776

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026